SeaStar Medical Holding Co. (NASDAQ:ICU) Short Interest Update

SeaStar Medical Holding Co. (NASDAQ:ICU) was the target of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 337,100 shares, an increase of 17.0% from the October 31st total of 288,100 shares. Currently, 8.2% of the company’s stock are short sold. Based on an average trading volume of 127,300 shares, the short-interest ratio is currently 2.6 days.

SeaStar Medical Trading Down 4.8 %

NASDAQ:ICU opened at $2.38 on Tuesday. The firm has a 50 day moving average of $3.30 and a 200-day moving average of $5.70. The stock has a market capitalization of $10.61 million, a P/E ratio of -0.20 and a beta of -1.13. SeaStar Medical has a 1 year low of $1.83 and a 1 year high of $42.92.

SeaStar Medical Company Profile

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.